Medical Oncology

, Volume 27, Issue 4, pp 1219–1226 | Cite as

Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor

  • Fei Liao
  • Weiguo DongEmail author
  • Lifang Fan
Original Paper


Hepatoma-derived growth factor (HDGF) is a novel multifunctional growth factor that elicits pleiotropic effects on biological processes such as lung remodeling and renal development. Recent studies demonstrated that HDGF is related to tumor proliferation, invasion, angiogenesis, and apoptosis. However, the molecular mechanism of HDGF’s involvement in apoptosis remains to be clarified. In this study, we first analyze the role of HDGF in colorectal carcinoma (CRC) progression by immunohistochemistry. Then we used small interference RNA (HDGF-siRNA) to block HDGF and assessed its effect on inducing apoptosis of CRC loVo cells. Apoptosis was detected using flow cytometry (FCM), DNA ladder analysis, and Hoechst 33258 staining. In addition, the expression levels of some apoptosis-related proteins were examined by western blot. The result showed that HDGF expression gradually increased in the colorectal carcinogenesis process. Further studies demonstrated that knock-down of HDGF can down-regulate the survivin, activate the mitochondrial pathway, and induce apoptosis in loVo cells. These findings suggest that HDGF is involved in colorectal carcinogenesis process. Further blocking HDGF exhibits potent pro-apoptotic properties in colon cancer cells. Thus, HDGF might be a potential therapeutic target for human colorectal cancer. These findings may have major implications in the treatment of colorectal cancer.


Hepatoma-derived growth factor Apoptosis Colorectal cancer Mitochondrial pathway 



This study was supported by a grant from the Natural Science Foundation of Hubei Province, China (project no. 2007AA301B33-3), as well as by the Medical Structural Biology Research Center of Wuhan University.


  1. 1.
    Nakamura H, Kambe H, Egawa T, et al. Partial purification and characterization of human hepatoma-derived growth factor. Clin Chim Acta. 1989;183:273–84.PubMedCrossRefGoogle Scholar
  2. 2.
    Enomoto H, Yoshida K, Kishima Y, et al. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation. Hepatology. 2002;36:1519–27.PubMedGoogle Scholar
  3. 3.
    Oliver JA, Al-Awqati Q. An endothelial growth factor involved in rat renal development. J Clin Invest. 1998;102:1208–19.PubMedCrossRefGoogle Scholar
  4. 4.
    Cilley RE, Zgleszewski SE, Chinoy MR. Fetal lung development: airway pressure enhances the expression of developmental genes. J Pediatr Surg. 2000;35:113–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Everett AD. Identification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart. Dev Dyn. 2001;222:450–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Mori M, Morishita H, Nakamura H, et al. Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Am J Respir Cell Mol Biol. 2004;30:459–69.PubMedCrossRefGoogle Scholar
  7. 7.
    Matsuyama A, Inoue H, Shibuta K, et al. Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer. Cancer Res. 2001;61:5714–7.PubMedGoogle Scholar
  8. 8.
    Zhou Z, Yamamoto Y, Sugai F, et al. Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus. J Biol Chem. 2004;279:27320–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Narron JV, Stoops TD, Barringhaus K, et al. Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration. Pediatr Res. 2006;59:778–83.PubMedCrossRefGoogle Scholar
  10. 10.
    Stec I, Nagl SB, van Ommen GJ, den Dunnen JT. The PWWP domain: a potential protein–protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett. 2000;473:1–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, et al. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Cancer. 2003;98:1444–56.PubMedCrossRefGoogle Scholar
  12. 12.
    Yamamoto S, Tomita Y, Hoshida Y, et al. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res. 2006;12:117–22.PubMedCrossRefGoogle Scholar
  13. 13.
    Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Oncol Rep. 2005;13:1075–80.PubMedGoogle Scholar
  14. 14.
    Lepourcelet M, Tou L, Cai L, et al. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development. 2005;132:415–27.PubMedCrossRefGoogle Scholar
  15. 15.
    Oyama K, Shiota G, Ito H, Murawaki Y, Kawasaki H. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis. 2002;23:885–92.PubMedCrossRefGoogle Scholar
  16. 16.
    Nakamura H, Izumoto Y, Kambe H, et al. Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J Biol Chem. 1994;269:25143–9.PubMedGoogle Scholar
  17. 17.
    Oliver JA, Al-Awqati Q. An endothelial growth factor involved in rat renal development. J Clin Invest. 1998;102:1208–19.PubMedCrossRefGoogle Scholar
  18. 18.
    Everett AD, Lobe DR, Matsumura ME, Nakamura H, McNamara CA. Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J Clin Invest. 2000;105:567–75.PubMedCrossRefGoogle Scholar
  19. 19.
    Mao J, Xu Z, Fang Y, Wang H, Xu J, Ye J, et al. Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation. Cancer Sci. 2008;99:2120–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Okuda Y, Nakamura H, Yoshida K, et al. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Cancer Sci. 2003;94:1034–41.PubMedCrossRefGoogle Scholar
  21. 21.
    Zhang J, Ren H, Yuan P, et al. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non–small cell lung cancer cells. Cancer Res. 2006;66:18–23.PubMedCrossRefGoogle Scholar
  22. 22.
    Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT. Downregulation of hepatoma-derived growth factor activates the bad-mediated apoptotic pathway in human cancer cells. Apoptosis. 2008;13:1135–47.PubMedCrossRefGoogle Scholar
  23. 23.
    Jiang H, Yu J, Guo H, Song H, Chen S. Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochem Biophys Res Commun. 2008;368:1–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2008;8:61–70.PubMedCrossRefGoogle Scholar
  25. 25.
    Muto Y, Moriwaki H, Ninomiya M, Adachi S, Hepatoma Prevention Study Group, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med. 1996;334:1561–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Holmes WF, Soprano DR, Soprano KJ. Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene. 2003;22:6377–86.PubMedCrossRefGoogle Scholar
  27. 27.
    Varbiro G, Veres B, Gallyas F Jr, Sumegi B. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med. 2001;31:548–58.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2009

Authors and Affiliations

  1. 1.Department of GastroenterologyRenmin Hospital of Wuhan UniversityWuhanPeople’s Republic of China
  2. 2.Pathology DepartmentWuhan UniversityWuhanPeople’s Republic of China

Personalised recommendations